177 related articles for article (PubMed ID: 24390218)
1. A novel hypoxia-associated subset of FN1 high MITF low melanoma cells: identification, characterization, and prognostic value.
Wouters J; Stas M; Govaere O; Barrette K; Dudek A; Vankelecom H; Haydu LE; Thompson JF; Scolyer RA; van den Oord JJ
Mod Pathol; 2014 Aug; 27(8):1088-100. PubMed ID: 24390218
[TBL] [Abstract][Full Text] [Related]
2. Inducibly decreased MITF levels do not affect proliferation and phenotype switching but reduce differentiation of melanoma cells.
Vlčková K; Vachtenheim J; Réda J; Horák P; Ondrušová L
J Cell Mol Med; 2018 Apr; 22(4):2240-2251. PubMed ID: 29369499
[TBL] [Abstract][Full Text] [Related]
3. IGF-1 contributes to the expansion of melanoma-initiating cells through an epithelial-mesenchymal transition process.
Le Coz V; Zhu C; Devocelle A; Vazquez A; Boucheix C; Azzi S; Gallerne C; Eid P; Lecourt S; Giron-Michel J
Oncotarget; 2016 Dec; 7(50):82511-82527. PubMed ID: 27764776
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia and MITF control metastatic behaviour in mouse and human melanoma cells.
Cheli Y; Giuliano S; Fenouille N; Allegra M; Hofman V; Hofman P; Bahadoran P; Lacour JP; Tartare-Deckert S; Bertolotto C; Ballotti R
Oncogene; 2012 May; 31(19):2461-70. PubMed ID: 21996743
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-like EMT inducer regulates partial phenotype switching in MITF-low melanoma cell lines.
Noguchi K; Dalton AC; Howley BV; McCall BJ; Yoshida A; Diehl JA; Howe PH
PLoS One; 2017; 12(5):e0177830. PubMed ID: 28545079
[TBL] [Abstract][Full Text] [Related]
6. Melanoma-associated genes, MXI1, FN1, and NME1, are hypoxia responsive in murine and human melanoma cells.
Olbryt M; Habryka A; Tyszkiewicz T; Rusin A; Cichoń T; Jarząb M; Krawczyk Z
Melanoma Res; 2011 Oct; 21(5):417-25. PubMed ID: 21912348
[TBL] [Abstract][Full Text] [Related]
7. Microphthalmia transcription factor in malignant melanoma predicts occult sentinel lymph node metastases and survival.
Naffouje S; Naffouje R; Bhagwandin S; Salti GI
Melanoma Res; 2015 Dec; 25(6):496-502. PubMed ID: 26317170
[TBL] [Abstract][Full Text] [Related]
8. Epithelial-to-mesenchymal-like transition events in melanoma.
Pedri D; Karras P; Landeloos E; Marine JC; Rambow F
FEBS J; 2022 Mar; 289(5):1352-1368. PubMed ID: 33999497
[TBL] [Abstract][Full Text] [Related]
9. Microphthalmia-associated transcription factor expression levels in melanoma cells contribute to cell invasion and proliferation.
Vachtenheim J; Ondrušová L
Exp Dermatol; 2015 Jul; 24(7):481-4. PubMed ID: 25866058
[TBL] [Abstract][Full Text] [Related]
10. Critical role of glioma-associated oncogene homolog 1 in maintaining invasive and mesenchymal-like properties of melanoma cells.
Gunarta IK; Li R; Nakazato R; Suzuki R; Boldbaatar J; Suzuki T; Yoshioka K
Cancer Sci; 2017 Aug; 108(8):1602-1611. PubMed ID: 28635133
[TBL] [Abstract][Full Text] [Related]
11. The immunohistochemistry of invasive and proliferative phenotype switching in melanoma: a case report.
Eichhoff OM; Zipser MC; Xu M; Weeraratna AT; Mihic D; Dummer R; Hoek KS
Melanoma Res; 2010 Aug; 20(4):349-55. PubMed ID: 20526217
[TBL] [Abstract][Full Text] [Related]
12. Molecular profiling of tumour budding implicates TGFβ-mediated epithelial-mesenchymal transition as a therapeutic target in oral squamous cell carcinoma.
Jensen DH; Dabelsteen E; Specht L; Fiehn AM; Therkildsen MH; Jønson L; Vikesaa J; Nielsen FC; von Buchwald C
J Pathol; 2015 Aug; 236(4):505-16. PubMed ID: 25925492
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia contributes to melanoma heterogeneity by triggering HIF1α-dependent phenotype switching.
Widmer DS; Hoek KS; Cheng PF; Eichhoff OM; Biedermann T; Raaijmakers MIG; Hemmi S; Dummer R; Levesque MP
J Invest Dermatol; 2013 Oct; 133(10):2436-2443. PubMed ID: 23474946
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic potential of the metabolic modulator phenformin in targeting the stem cell compartment in melanoma.
Petrachi T; Romagnani A; Albini A; Longo C; Argenziano G; Grisendi G; Dominici M; Ciarrocchi A; Dallaglio K
Oncotarget; 2017 Jan; 8(4):6914-6928. PubMed ID: 28036292
[TBL] [Abstract][Full Text] [Related]
15. Gene expression profiling identifies microphthalmia-associated transcription factor (MITF) and Dickkopf-1 (DKK1) as regulators of microenvironment-driven alterations in melanoma phenotype.
Hartman ML; Talar B; Noman MZ; Gajos-Michniewicz A; Chouaib S; Czyz M
PLoS One; 2014; 9(4):e95157. PubMed ID: 24733089
[TBL] [Abstract][Full Text] [Related]
16. Exploiting Honokiol-induced ER stress CHOP activation inhibits the growth and metastasis of melanoma by suppressing the MITF and β-catenin pathways.
Chiu CS; Tsai CH; Hsieh MS; Tsai SC; Jan YJ; Lin WY; Lai DW; Wu SM; Hsing HY; Arbiser JL; Sheu ML
Cancer Lett; 2019 Feb; 442():113-125. PubMed ID: 30391358
[TBL] [Abstract][Full Text] [Related]
17. Analysis of DNA methylation patterns in the tumor immune microenvironment of metastatic melanoma.
Mitra S; Lauss M; Cabrita R; Choi J; Zhang T; Isaksson K; Olsson H; Ingvar C; Carneiro A; Staaf J; Ringnér M; Nielsen K; Brown KM; Jönsson G
Mol Oncol; 2020 May; 14(5):933-950. PubMed ID: 32147909
[TBL] [Abstract][Full Text] [Related]
18. Collagen abundance controls melanoma phenotypes through lineage-specific microenvironment sensing.
Miskolczi Z; Smith MP; Rowling EJ; Ferguson J; Barriuso J; Wellbrock C
Oncogene; 2018 Jun; 37(23):3166-3182. PubMed ID: 29545604
[TBL] [Abstract][Full Text] [Related]
19. Mitf regulation of Dia1 controls melanoma proliferation and invasiveness.
Carreira S; Goodall J; Denat L; Rodriguez M; Nuciforo P; Hoek KS; Testori A; Larue L; Goding CR
Genes Dev; 2006 Dec; 20(24):3426-39. PubMed ID: 17182868
[TBL] [Abstract][Full Text] [Related]
20.
Ennen M; Keime C; Gambi G; Kieny A; Coassolo S; Thibault-Carpentier C; Margerin-Schaller F; Davidson G; Vagne C; Lipsker D; Davidson I
Clin Cancer Res; 2017 Nov; 23(22):7097-7107. PubMed ID: 28855355
[No Abstract] [Full Text] [Related]
[Next] [New Search]
